Retraction notices

Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis

Type
Retraction
Notice date
2/17/2020 0:00
Journal
Journal of Experimental & Clinical Cancer Research: (CR)
Publisher
Springer
Notice DOI
10.1186/s13046-020-1538-8
Original paper DOI
10.1186/s13046-019-1324-7

Reasons